Evan E. Opas
Impact in
-
- Bone health and osteoporosis research
- Bone and Joint Diseases
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Bone Metabolism and Diseases 5
- Receptor Mechanisms and Signaling 3
- Chemical Synthesis and Analysis 3
- Oncology 12
- Chemokine receptors and signaling 6
- Bone health and treatments 5
- Co-authors
- Philip J. Vickers (1 shared paper)Richard A. F. Dixon (1 shared paper)Ronald E. Diehl (1 shared paper)Elaine Rands (1 shared paper)John W. Gillard (1 shared paper)Douglas K. Miller (1 shared paper)Jilly F. Evans (1 shared paper)Maurice B. Feinstein (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Biochemical Pharmacology (4 papers)Maturitas (3 papers)Annals of the New York Academy of Sciences (2 papers)Bone (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Evan E. Opas
34 papers receiving 2.0k citations
Evan E. Opas's Hit Papers
Peers
Comparison fields: 5 of 111
- Orthopedics and Sports Medicine 375
- Biochemistry 189
- Oncology 606
- Pharmacology 283
- Physiology 369
Countries citing papers authored by Evan E. Opas
This map shows the geographic impact of Evan E. Opas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan E. Opas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan E. Opas more than expected).
Fields of papers citing papers by Evan E. Opas
This network shows the impact of papers produced by Evan E. Opas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan E. Opas. The network helps show where Evan E. Opas may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan E. Opas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis Hit paper breakdown → | 1990 | 666 |
| 2 | 1993 | 348 | |
| 3 | 1996 | 178 | |
| 4 | 1981 | 139 | |
| 5 | 1985 | 112 | |
| 6 | 1999 | 79 | |
| 7 | 1983 | 74 | |
| 8 | 2014 | 70 | |
| 9 | 1986 | 57 | |
| 10 | 1996 | 55 | |
| 11 | 2005 | 30 | |
| 12 | 1997 | 30 | |
| 13 | 1991 | 24 | |
| 14 | 1988 | 24 | |
| 15 | 1987 | 24 | |
| 16 | 2004 | 23 | |
| 17 | 2011 | 20 | |
| 18 | 2012 | 18 | |
| 19 | 2012 | 18 | |
| 20 | 2014 | 18 |
About Evan E. Opas
Evan E. Opas is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Pharmacology, having authored 34 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (6 papers), Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (5 papers), Bone Metabolism and Diseases (5 papers), Bone health and treatments (5 papers), Receptor Mechanisms and Signaling (3 papers), Chemical Synthesis and Analysis (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (375 citations), Biochemistry (189 citations), Oncology (606 citations), Pharmacology (283 citations) and Physiology (369 citations). Evan E. Opas has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Philip J. Vickers, Richard A. F. Dixon, Ronald E. Diehl, Elaine Rands, John W. Gillard, Douglas K. Miller, Jilly F. Evans, Maurice B. Feinstein, John L. Humes and Gideon A. Rodan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Maturitas, Annals of the New York Academy of Sciences and Bone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.